The effect of decreasing renal function on lipoprotein profiles

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review

(2009) Marianne Benn   ATHEROSCLEROSIS

Persistent Inflammation as a Catalyst for Other Risk Factors in Chronic Kidney Disease: A Hypothesis Proposal

(2009) J. J. Carrero et al.   Clinical Journal of the American Society of Nephrology

Dyslipidemia of kidney disease

(2009) Per-Ola Attman et al.   CURRENT OPINION IN LIPIDOLOGY

Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III

(2009) Doris T. Chan et al.   JOURNAL OF LIPID RESEARCH

Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis

(2009) Bengt C. Fellström et al.   NEW ENGLAND JOURNAL OF MEDICINE

Apolipoprotein CIII and Atherosclerosis

(2008) Alex Bobik   CIRCULATION

Increased Plasma Apolipoprotein C-III Concentration Independently Predicts Cardiovascular Mortality: The Hoorn Study

(2008) P. G. Scheffer et al.   CLINICAL CHEMISTRY

Vascular and metabolic effects of treatment of combined hyperlipidemia: Focus on statins and fibrates

(2007) Kwang Kon Koh et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY